Tegumentary leishmaniasis in the State of Amazonas: what have we learned and what do we need?

This study evaluated the occurrence of American tegumentary leishmaniasis (ATL) in the State of Amazonas, Brazil, in the last 30 years with emphasis on the last 10 years (2001 to 2010). The disease was predominantly observed in males (76.2%), in the 21- to 30-year-old age group (26.6%) and in extractive workers (43.7%); 3.3% of the cases were the mucosal form. The endemic channel shows the disease seasonality, with a predominance of cases at the beginning and end of each year. The number of cases by municipality in the period of 2001-2010 shows the maintenance of the endemic in the localities where the highest numbers of cases have always been registered, namely, Manaus, Rio Preto da Eva, Itacoatiara and Presidente Figueiredo. The comparison of data from 2001 to 2005 and from 2006 to 2010 showed the emergence of this disease in municipalities that had been previously unaffected. In the last years, there has been a significant increase in the activities of control, diagnosis and treatment of leishmaniasis in the State of Amazonas. In conclusion, the historical series of ATL analyzed in this study suggests that the transmission foci remain and are even expanding, though without continuous transmission in the intra- or peridomicile settings. Moreover, the disease will persist in the Amazon while the factors associated with infection acquisition relative to forest exploitation continue to have economic appeal. There is a real expectation of wide variations in disease incidence that can be influenced by climate and economic aspects.

[1]  E. Pública PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL , 2014 .

[2]  J. Cano,et al.  Leishmaniasis Worldwide and Global Estimates of Its Incidence , 2012, PloS one.

[3]  P. Machado,et al.  Combining diagnostic procedures for the management of leishmaniasis in areas with high prevalence of Leishmania guyanensis. , 2011, Anais brasileiros de dermatologia.

[4]  R. M. S. Silva Júnior,et al.  A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis. , 2011, Anais brasileiros de dermatologia.

[5]  A. Siqueira,et al.  American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian Amazon. , 2011, The American journal of tropical medicine and hygiene.

[6]  H. Silveira,et al.  Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon , 2011, PLoS neglected tropical diseases.

[7]  R. Dietze,et al.  Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil. , 2011, The American journal of tropical medicine and hygiene.

[8]  E. Chagas ROY AL SOCIETY OF TROPICAL MEDICINE AND HYGIENE , 2011 .

[9]  Gilmar Rosa,et al.  [American tegumentary leishmaniasis in children: epidemiological aspects of cases treated in Manaus, Amazonas, Brazil]. , 2007, Cadernos de saude publica.

[10]  Jorge Augusto de Oliveira Guerra,et al.  Estudo de dois anos com animais reservatórios em área de ocorrência de leishmaniose tegumentar americana humana em bairro de urbanização antiga na cidade de Manaus-AM, Brasil , 2007 .

[11]  L. Coelho,et al.  [Epidemiology of tegumentary leishmaniasis in São João, Manaus, Amazonas, Brazil]. , 2006, Cadernos de saude publica.

[12]  R. Lainson,et al.  Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. , 2004, Memorias do Instituto Oswaldo Cruz.

[13]  S. Talhari,et al.  [Clinical and diagnostic aspects of American tegumentary leishmaniosis in soldiers simultaneously exposed to the infection in the Amazon Region]. , 2003, Revista da Sociedade Brasileira de Medicina Tropical.

[14]  M. V. Guerra,et al.  Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. , 2001, The American journal of tropical medicine and hygiene.

[15]  M. V. Guerra,et al.  Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Senra,et al.  Leishmaniasis in Manaus, Brazil. , 1989, Parasitology today.

[17]  R. D. Naiff,et al.  Leishmaniose no estados do Amazonas. Aspectos epidemiológicos, clínicos e terapêuticos , 1988 .

[18]  P. Marsden Pentavalent antimonials: old drugs for new diseases , 1985 .

[19]  R. D. Naiff,et al.  Tratamento da leishmaniose tegumetar americana. Resultados preliminares com a pentamidina , 1985 .

[20]  Gabriel Grimaldi Júnior Leishmanioses tegumentares: aspectos clínicos e imunopatológicos , 1982 .

[21]  G. Grimaldi [Cutaneous leishmaniasis: clinical and immunopathological aspects]. , 1982, Memorias do Instituto Oswaldo Cruz.

[22]  F. Pajot,et al.  Epidemiology of leishmaniasis in French Guiana. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  M. Miles,et al.  The opossum, Didelphis marsupialis (Marsupialia: Didelphidae), as a reservoir host of Leishmania braziliensis guyanensis in the Amazon Basin of Brazil. , 1981, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  J. Shaw,et al.  Leishmaniasis in Brazil: XVI. Isolation and identification of Leishmania species from sandflies, wild mammals and man in north Para State, with particular reference to L. braziliensis guyanensis causative agent of "pian-bois". , 1981, Transactions of the Royal Society of Tropical Medicine and Hygiene.